In the News

Newer oral diabetes meds could provide significant benefits in type 1 diabetes

A retrospective chart review found that glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors were associated with benefits including weight loss and reduced use of insulin in patients with type 1 diabetes.

Annual screening for albuminuria may not be necessary in all patients with type 1 diabetes

A recent study found that personalizing the timing of testing based on patients' albumin excretion rate and HbA1c level could reduce time with undetected kidney disease as well as testing frequency.

Diabetes and prior CVD may no longer carry equivalent cardiovascular risk

In a population-based Canadian study, the magnitude of the association between diabetes and risk of cardiovascular events decreased while that between cardiovascular disease (CVD) and such events remained stable.

MKSAP quiz: Diabetic ketoacidosis at diagnosis

This month's quiz asks readers to choose a treatment for a young woman who was hospitalized for diabetic ketoacidosis six weeks ago but had been previously well and was discharged on basal-bolus insulin.

Spotlight on diabetes and chronic kidney disease

A study showed that chronic kidney disease has declined among U.S. adults with diabetes. A meta-analysis found that sodium-glucose cotransporter-2 inhibitors prevented kidney decline similarly in those with and without diabetes. A survey identified knowledge gaps among prescribers on this topic.

Some newer diabetes drugs may help decrease risk of COPD exacerbation

A cohort study in the United Kingdom found that chronic obstructive pulmonary disease (COPD) exacerbations were less common in patients with type 2 diabetes and COPD taking glucagon-like peptide-1 receptor agonists or sodium-glucose cotransporter-2 inhibitors versus sulfonylureas.

More than 15% of U.S. insulin users had to ration in the past year, study finds

Rationing was more common among younger patients, Black patients, and uninsured patients, according to an analysis of the 2021 National Health Interview Survey.

Case reports involving diabetes published

New case reports describe osteomyelitis pubis and nonislet cell tumor hypoglycemia.